Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
29
An NIH-sponsored, multi-year study of hundreds of women diagnosed with breast cancer found that Positron Emission Mammography (PEM) scanners significantly outperform MRI when differentiating between benign and cancerous lesions.
Sentinel-lymph-node (SLN) mapping and biopsy maintains staging accuracy in early breast cancer and identifies patients for selective lymphadenectomy. SLN mapping requires injection of technetium-99m-sulfur colloid-an effective but sometimes painful method, for which better pain-management strategies are needed, investigators in the United States report.
Clemson University researchers in collaboration with researchers at the University of Bremen, Germany, are working to make the physical pain and discomfort of mammograms a thing of the past, while allowing for diagnostic imaging eventually to be done in a home setting.
28
Although Breast Cancer Awareness Month is coming to an end, smart women know that taking care of their health is important throughout the year. What's more, women age 25 and older now have a tool to help them understand their potential risk for breast cancer. Based on the same science as the PAP test for cervical cell changes, HALO(R) is the only FDA-cleared risk assessment tool for non-hereditary breast cancer.
27
The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow.
ImmunoCellular Therapeutics, Ltd. (IMUC), a biotechnology company that is focused on the development of novel immune-based cancer therapies, today announced additional data from its Phase I clinical trial evaluating ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme (GBM).
NeoPharm, Inc. today announced that it has submitted a Phase II protocol to the FDA for the study of liposome entrapped docetaxel (LE- DT), a novel, proprietary liposomal delivery system of docetaxel, the active ingredient of Taxotere(R), for locally advanced or metastatic pancreatic cancer patients.
26
In a review article published this month in The Oncologist, UNC's Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease.
Does it make sense to offer cancer screenings to older adults? Experts' opinions vary. The Tribune asked several leading organizations to describe their policies for people considered to be low risk, without symptoms of potential illness.
When Ellen Currotto was diagnosed with breast cancer, when part of her breast was removed, when she endured weeks of chemotherapy and lost her hair, when she underwent radiation, all of these months she focused on just one thing: Being done.
We care about your feedback. Let us know how we can improve your CancerCompass experience.